Clicky

Frontage Holdings Corp(1521)

Description: Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services that include study designs, execution of studies, and interpretation of the data through structural optimization in early discovery, pharmacokinetic studies in rodents, non- GLP bioanalytical studies, etc. The company also provides safety and toxicology services comprising in-vitro and in-vivo studies; bioequivalence services, which consist of designing, coordinating, and reporting of bioequivalence studies; chemistry services comprising contract research and custom synthesis services; and clinical services, such as early stage clinical, BE/BA, biometric, and data management services. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.


Keywords: Biotechnology Life Sciences Clinical Research Laboratory Services Pharmacokinetics Control Services Clinical Services Data Management Services Laboratory Testing Services Drug Metabolism Contract Research Organization Bioequivalence Chemistry Services Synthesis Services

Home Page: www.frontagelab.com

700 Pennsylvania Drive
Exton, PA 19341
United States
Phone: 610 232 0100


Officers

Name Title
Dr. Song Li Ph.D. Founder, CEO & Chairman
Mr. Jianmin Wang Chief Financial Officer
Mr. Richard Fischetti J.D. VP & Gen. Counsel of Frontage Labs
Dr. Zhongping Lin Ph.D. Exec. VP and Global Head of Bioanalytical & Biologics Services
Dr. Dongmei Wang Ph.D. Exec. VP for Global CMC Services
Dr. Tianyi Zhang Sr. VP of the Group & GM of Frontage Shanghai
Dr. Abdul Ezaz Mutlib Ph.D. Exec. VP
Mr. Glenn Washer B.Sc., D.A.B.T, DABT Pres of North America Operations
Dr. Yining Qi M.D., M.P.H. M.B.A. Pres of China Operations
Mr. Sudendra Rao Ph.D. Sr. VP of HR - North America

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 28.9855
Trailing PE: 33
Price-to-Book MRQ: 1.8703
Price-to-Sales TTM: 26.5334
IPO Date:
Fiscal Year End: December
Full Time Employees: 1505
Back to stocks